Imaging may help predict NSCLC response to chemoradiotherapy

07/22/2013 | HealthImaging.com

A study in the Journal of Nuclear Medicine reported on the efficacy of F-18 FDG PET in predicting non-small cell lung cancer response to concomitant chemoradiotherapy. Researchers performed FDG PET scans on 28 patients before treatment, at the end of the second week of treatment and two weeks and three months after the completion of treatment. "The current study in locally advanced NSCLC patients treated with concomitant chemoradiotherapy indicates that early in treatment F-18 FDG PET can be used to predict outcome," researchers wrote.

View Full Article in:

HealthImaging.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC